AFP and hepatocellular carcinoma: In patients with cirrhosis, comparable diagnostic sensitivity for HCC were observed between AFP-L3 and AFP in two American and one European prospective phase 3 studies (Beudeker et al. 2023; Singal et al. 2022b; Tayob et al. 2023) (Table 1).